Correspondence 0001493152-24-037950 from Imunon, Inc. (IMNN)

Imunon, Inc.
Date: Sept. 24, 2024 · CIK: 0000749647 · Accession: 0001493152-24-037950

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-281834

Date

September 26, 2024

Author

Form

CORRESP

Company

Imunon, Inc.

Letter

Re: Imunon, Inc. (the “Company”)

September 24, 2024

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attn: Daniel Crawford

Registration Statement Filed on Form S-1 (the “Registration Statement”)

File No. 333-281834

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 5:00 p.m., Eastern Time, on September 26, 2024, or as soon as practicable thereafter.

Please contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

Respectfully,
Imunon, Inc.

Show Raw Text

CORRESP
1
filename1.htm

September
24, 2024

Via
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attn: Daniel Crawford

    Re:
    Imunon,
    Inc. (the “Company”)

    Registration
    Statement Filed on Form S-1 (the “Registration Statement”)

    File
    No. 333-281834

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effective date for the above-referenced
Registration Statement be accelerated to 5:00 p.m., Eastern Time, on September 26, 2024, or as soon as practicable thereafter.

Please
contact Megan Gates of Covington & Burling LLP at (617) 603-8805 or mgates@cov.com with any questions you may have regarding this
request. In addition, please notify Ms. Gates by telephone when this request for acceleration has been granted.

    Respectfully,

    Imunon, Inc.

    By:
    /s/
    David Gaiero

    Name:
    David
    Gaiero

    Title:
    Chief
    Financial Officer

    cc:
    Megan
    Gates, Covington & Burling LLP

SecProbe.io